• GFC Life Science CEO Kang Hee Cheol's combined holding with related parties rose to 37.64% from 37.62%.
• Kang purchased 1,425 voting shares on the open market during Oct. 13-15, 2026.
• As of Oct. 19, the group's voting shareholding totaled 1,963,792 shares, representing 36.88%, up from 36.85%.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. GFC Life Science Co. Ltd. published the original content used to generate this news brief via DART, the regulatory disclosure system operated by the South Korea Financial Supervisory Service (FSS) (Ref. ID: 20261019000242), on October 19, 2026, and is solely responsible for the information contained therein.